The value of biomarkers in diagnosis and treatment of heart failure with preserved ejection fraction retention / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): 1224-1234, 2023.
Article
in Zh
| WPRIM
| ID: wpr-1029873
Responsible library:
WPRO
ABSTRACT
Heart failure with preserved ejection fraction (HFpEF)is a heterogeneous disease, and as a systemic syndrome, it presents different clinical course and prognosis. Currently, HF is not effective in its treatment. For the diagnosis and treatment of HFpEF, at present and in the future, should we focus more on the biomarkers involving the "crosstalk" between organs such as heart-liver-lung-kidney, based on the good application of existing commonly used markers, such as high-sensitivity troponin and BNP/NT-proBNP.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Laboratory Medicine
Year:
2023
Type:
Article